CellCarta is a global leader in precision medicine testing services, specialising as a Contract Research Organisation (CRO) that supports the pharmaceutical industry through a comprehensive range of laboratory services. By leveraging state-of-the-art technology and an expert team, CellCarta provides critical insights that help in the development and delivery of innovative therapies, enhancing the capabilities of its clients in driving successful health outcomes.

Services include:
– Immunology
– Histopathology
– Proteomics
– Genomics
– Digital Pathology/AI
– Biomarker development
– Clinical trial support
– Companion diagnostics

CellCarta is dedicated to advancing the science of precision medicine, ensuring that biopharmaceutical companies receive the highest quality support in their research and development efforts. For further information, please visit cellcarta.com.